Skip to content

Fortune on Allcyte

Posted on March 25, 2021 by snijderlab.org

How cool, Fortune Magazine has written a piece on our spinoff company Allcyte. Allcyte uses and develops the Pharmacoscopy platform to bring tailored treatments to each cancer patient.

This startup has found a way to uncover bespoke cancer therapies https://t.co/T7zdxoHbOJ

— Berend Snijder (@BerendSnijder) March 25, 2021
Posted in News

Post navigation

Previous Post Introducing the Tumor Profiler
Next Post @snijderlab on Twitter

Recent Posts

  • Snijder Lab → BIIE March 27, 2025
  • GBM @ Nature Medicine September 26, 2024
  • Lab retreat 2024 August 23, 2024
  • T cell architecture @ Science June 5, 2024
  • Myelofibrosis @ Nature Comms October 13, 2023
  • 2nd Successful clinical trial July 14, 2023
  • Myeloma study @ Nature Cancer April 21, 2023
  • Phenoplexing @ SciAdv November 5, 2022
  • Deep Morphology Learning November 2, 2022
  • Immune wiring + pharmacoscopy @ Nature August 6, 2022

Archives

  • March 2025(1)
  • September 2024(1)
  • August 2024(1)
  • June 2024(1)
  • October 2023(1)
  • July 2023(1)
  • April 2023(1)
  • November 2022(2)
  • August 2022(1)
  • February 2022(1)
  • July 2021(1)
  • April 2021(1)
  • March 2021(1)
  • January 2021(1)
  • November 2020(1)
  • September 2020(1)
  • July 2020(3)
  • June 2020(2)
  • February 2020(1)
  • January 2020(1)
  • December 2019(2)
  • November 2019(1)
  • October 2019(1)
  • May 2019(1)
  • March 2019(1)
  • November 2018(2)
  • October 2018(1)
  • July 2018(1)
  • November 2017(1)
  • August 2017(1)
  • March 2017(1)
  • September 2016(1)